Position in KMDA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$16,793
-$22,455 QoQ
Shares Held
2,288
-51.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 51 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in KMDA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NewEdge Advisors, LLC holds $12,323,215 across 27 Drug Manufacturers - Specialty & Generic names. KMDA ranks #13 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
36,078 | $2,592,565 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
12,619 | $2,126,806 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
3,861 | $2,092,005 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
37,994 | $1,287,236 | |
| 5 | HLN |
Haleon plc
|
133,508 | $1,245,629 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
21,721 | $753,067 | |
| 7 | VTRS |
Viatris Inc
|
39,976 | $634,818 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
16,739 | $605,951 |
All Filings in KMDA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,793 | 2,288 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $39,248 | 4,706 | Shares | Sole | 2026-06-03 | |
| 2025-12-31 | $406,218 | 57,538 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $365,515 | 52,668 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $391,708 | 50,543 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $341,479 | 51,661 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $143,090 | 23,496 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $81,817 | 15,236 | Shares | Sole | 2024-11-14 | |
| 2023-12-31 | $16,670 | 2,724 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||